↓ Skip to main content

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

Overview of attention for article published in BMC Nephrology, February 2011
Altmetric Badge

Readers on

mendeley
52 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design
Published in
BMC Nephrology, February 2011
DOI 10.1186/1471-2369-12-8
Pubmed ID
Authors

Howard Trachtman, Suzanne Vento, Debbie Gipson, Larysa Wickman, Jennifer Gassman, Melanie Joy, Virginia Savin, Michael Somers, Maury Pinsk, Tom Greene

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Slovenia 1 2%
Unknown 50 96%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Researcher 6 12%
Student > Master 5 10%
Professor 4 8%
Student > Bachelor 4 8%
Other 15 29%
Unknown 12 23%
Readers by discipline Count As %
Medicine and Dentistry 26 50%
Psychology 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 6%
Nursing and Health Professions 2 4%
Unspecified 2 4%
Other 3 6%
Unknown 12 23%